Eloxx Pharmaceuticals ELOX
$ 3.82
-5.68%
Quarterly report 2023-Q3
added 11-13-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Robert Ward |
Employees in the company |
29 |
Shares |
2.17 M |
Market Cap[1] |
$ 8.28 M |
EBITDA (LTM) |
$ -33.8 M |
P/E (LTM) |
-0.4 |
P/S (LTM) |
- |
EPS (LTM) |
-9.62 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.